AG Clark Issues Joint Statement Affirming Safety of and Access to Mifepristone

Despite FDA's Unnecessary and Baseless Comments , Mifepristone Remains Safe and Available

Attorney General Charity Clarktoday joined a coalition of 20 attorneys general in issuing a joint statement addressing concerns over a U.S. Food and Drug Administration (FDA) review of mifepr istone. This review was referenced by Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Makary in response to a letter from Republican state attorneys general to the FDA calling for restrictions on or withdrawal of mifepristone from the market:

"For more than 25 years, mifepristone has been used safely and effectively in the United States and globally. It is currently the most common method for early-term abortion care in the United States and is the standard of care for managing early miscarriage. The decision to reexamine access to this medication was made in response to a scientifically baseless letter and ignores decades of research that proves mifepristone is safe and effective. Medical decisions should be left between patients, their families, and their providers - and they should be guided by science, not political agendas.

As state attorneys general, we have a responsibility to enforce state laws and protect our residents, including their access to reproductive care. If access to mifepristone is challenged, we will take action to protect it."

Joining Attorney General Clarkin issuing this statement are the attorney generals of Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, New York, Oregon, Rhode Island, and Washington.

CONTACT: Amelia Vath, Senior Advisor to the Attorney General, 802-828-3171